HEALTH● LOWJun 29 · Jun 29, 2026, 9:50 PM
Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing
Seeking Alpha Tech
Eli Lilly and Regeneron have been selected for an FDA pilot program aimed at enhancing drug manufacturing within the United States. This initiative seeks to strengthen domestic pharmaceutical production.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH29m agoLost your spark? The "silent sister" of depression, and a quiz to spot herNPR NewsHEALTH59m agoEbola: Africa CDC warns continent ‘not winning’ as cases surpass 10,000Premium TimesHEALTH1h ago‘One in 4 Nigerian stroke patients under 50’Vanguard NigeriaHEALTH1h agoThe national government issued a list of recommendations to prevent and detect a dangerous avian disease after an outbreak in BrazilClarín